119431-22-0Relevant articles and documents
omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
-
, (2008/06/13)
This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
OMEGA-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
-
Page/Page column 10, (2010/01/31)
This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
Omega-carboxyaryl subsituted diphenyl ureas as raf kinase inhibitors
-
, (2008/06/13)
This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.